Вклад участника
- 23:30, 29 апреля 2024 (разн. | история) . . (+3364) . . Н Any-headtohead-comparison-of-ixekizumab-as-opposed-to-guselkumab-within-patients-along-with-moderatetosevere-cavity-enducing-plaque-skin-psoriasis-24week-efficacy-and-also-basic-safety-is-a-result-of-any-randomized-doubleblinded-tryout-o (Any-headtohead-comparison-of-ixekizumab-as-opposed-to-guselkumab-within-patients-along-with-moderatetosevere-cavity-enducing-plaque-skin-psoriasis-24week-efficacy-and-also-basic-safety-is-a-result-of-any-randomized-doubleblinded-tryout-o) (текущая)